SCHEMBL19930236

SCHEMBL19930236

CC[C@H](C)COc1ccc(C(C)(C)c2ccc(OC[C@@H](Cl)CC)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.47
HTT P42858 2/20 0.44
HIF1A Q16665 2/20 0.44
FFAR1 O14842 1/20 0.42
KMT2A Q03164 5/20 0.40
MEN1 O00255 4/20 0.40
KDM4E B2RXH2 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
GAA P10253 1/20 0.40
ALDH1A1 P00352 3/20 0.39
TP53 P04637 2/20 0.39
MAPT P10636 2/20 0.39
HPGD P15428 2/20 0.39
TSHR P16473 2/20 0.39
CYP1A2 P05177 1/20 0.39
PPARG P37231 1/20 0.39
PSMB1 P20618 1/20 0.36
PSMB5 P28074 1/20 0.36
PSMB2 P49721 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19930237 1.00 AR (0.47) ARHTTHIF1AFFAR1KMT2A
SCHEMBL19930233 1.00 AR (0.47) ARHTTHIF1AFFAR1KMT2A
SCHEMBL26396109 1.00 AR (0.47) ARHTTHIF1AFFAR1KMT2A
SCHEMBL19930235 1.00 AR (0.47) ARHTTHIF1AFFAR1KMT2A
SCHEMBL10284757 0.91 HTT (0.51) ARHTTHIF1AFFAR1KMT2A
SCHEMBL19482760 0.86 AR (0.55) ARHTTHIF1AFFAR1KMT2A
SCHEMBL801370 0.84 HTT (0.47) ARHTTHIF1AFFAR1KMT2A
SCHEMBL19930223 0.84 AR (0.56) ARHTTHIF1AFFAR1KMT2A
SCHEMBL19930224 0.84 AR (0.56) ARHTTHIF1AFFAR1KMT2A
SCHEMBL19930222 0.84 AR (0.56) ARHTTHIF1AFFAR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11779550-B2 Bisphenol ether derivatives and methods for using the same THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2023-10-10 US disclosed
US-20180064657-A1 BISPHENOL ETHER DERIVATIVES AND METHODS FOR USING THE SAME NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180064657-A1 BISPHENOL ETHER DERIVATIVES AND METHODS FOR USING THE SAME AR, SHBG, ESRRA AR 1/4885HTT 4135/4885HIF1A 3212/4885
US-11779550-B2 Bisphenol ether derivatives and methods for using the same AR, SHBG, ESRRA AR 1/4885HTT 4146/4885HIF1A 3256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.